Confronting History and Health Inequities Together
October 20th 2023“There are things more important than our discomfort, and there are things that are more important than even our fear—inclusion is more important,” said Erica Marsh, MD, MSCI. “Our care of our patients and loved ones is more important, and our existence tomorrow has to be more important than our fears today.”
Read More
Three US senators asked the Social Security Administration to respond to a report saying it reduced or suspended benefits for those who received COVID-19 relief payments; mifepristone, a drug taken to help manage miscarriages, remains widely unavailable to patients experiencing pregnancy loss; pharmaceutical companies are beginning trials to get weight-loss shots approved for patients with obesity 6 years and older.
Read More
Cultural Humility, Pioneering Leadership Are Key to Address Health Disparities
October 19th 2023Valerie Montgomery Rice, MD, FACOG, a distinguished infertility specialist, highlights the pivotal role of cultural humility, diversity, acknowledgment of historical injustices, and collective action in addressing disparities and fostering equitable access to health care.
Read More
Beyond Roe: Abortion Rights, Equity, and the Path Forward
October 18th 2023In the aftermath of the Dobbs v Jackson Women’s Health Organization ruling, Anita Allen, PhD, highlights the challenges to abortion rights in the United States, emphasizing disparities faced by marginalized communities, outlining threats to reproductive health care, and calling for collective action and advocacy to defend constitutional privacy and uphold the dignity of all individuals.
Read More
Stigma About Obesity Keeps Patients From Seeking Care, Creating Nationwide Disparities
October 18th 2023Panelists at AMCP Nexus provided an overview of the US obesity epidemic, dispelling myths about the causes of obesity, highlighting racial and economic disparities across the nation, and tackling how the managed care space can ensure accessibility to care for all patients.
Read More
Research Highlights Racial Disparities in US Sperm Donor Banks
October 18th 2023"The racial and ethnic distribution of United States sperm donors differs significantly from the United States population, particularly for those of African American or Black descent,” Cassie Hobbs, MD, explained.
Read More
Call for Cultural Considerations When Screening Oocyte Donors and Gestational Carriers
October 17th 2023Wiyatta Fahnbulleh, PsyD, and Pamela Blackwell, PsyD, LMSW, presented on the cultural limitations of the Personality Assessment Inventory and Minnesota Multiphasic Personality Inventory for assessing individuals for third-party reproduction.
Read More
Progress in Male Contraception: An Unmet Need in an Epidemic of Unplanned Pregnancy
October 17th 2023Nearly 50% of pregnancies worldwide are unplanned, leading to significant health, economic, and environmental consequences, Stephanie Page, MD, PhD, explains in her presentation at the American Society for Reproductive Medicine 2023 Scientific Congress & Expo.
Read More
Oncology Financial Navigator Ensures Vital Care Access, Eases Economic Burden
October 13th 2023According to the National Cancer Institute, in the year following a cancer diagnosis, the average cost of medical care plus medication exceeds $42,000, with some treatments having a price tag of more than $1 million.
Read More
ASRM 2023: Integrating Advances and Addressing Challenges in Reproductive Medicine
October 13th 2023The American Society of Reproductive Medicine (ASRM) 2023 Scientific Congress & Expo in New Orleans will focus on the latest advancements and challenges in reproductive health, including new treatments and technology, evolving legislation, and the importance of professional guidelines.
Read More
Medicare Part A and B premiums are set to increase by $9.80 next year; 20 experts from various specialties and institutions have developed updated brain death guidelines; many Black patients are strongly affected by multiple COVID-19 infections due to a lack of health insurance and health care access.
Read More
Evaluating WHO's Hemophilia Treatment Choices: Patient Safety, Access Challenges
October 12th 2023A commentary questions the characterization of cryoprecipitate, which is not pathogen-reduced, as an alternative modality for treating hemophilia, despite its substantial risk of transmitting blood-borne pathogens to patients.
Read More
Empathy, Support Are Crucial to Help Patients With Methamphetamine-Related Pulmonary Hypertension
October 11th 2023With methamphetamines continuing to inflict damage on the Western United States, panelists at the CHEST Annual Meeting 2023 shared sobering statistics and important considerations in treating patients with pulmonary hypertension associated with use of this destructive drug.
Read More
Review Details Strategies for Mitigating Bias in Clinical Algorithms
October 10th 2023Based on the comprehensive findings of a review, investigators outline several crucial policy implications, each designed to address the complex issue of bias mitigation in clinical algorithms effectively.
Read More
Air Pollution, Lung Health, and the Role of the Pulmonologist
October 10th 2023Amid the impacts of climate change, industrial emissions, and environmental disasters, pulmonologists and other clinicians will need to deliver actionable advice on how to reduce the risks to lung health posed by air pollution, according to panelists at the CHEST Annual Meeting 2023.
Read More
Keys to Achieving Equity in Lung Cancer Screening Include Erasing Stigma, Tackling Systemic Barriers
October 9th 2023Increasing lung cancer screening uptake without tailoring outreach and follow-up for underserved populations risks magnifying the existing racial and ethnic disparities in screening, so thoughtful approaches are needed to close the gaps, according to speakers at the CHEST Annual Meeting 2023.
Read More
Avidity Biosciences Gains FDA Orphan Drug Designation for Patients With DMD
October 9th 2023Sarah Boyce, president and CEO at Avidity Biosciences, discusses her leading role at the company, as well as antibody oligonucleotide conjugate drug, AOC 1044, currently in development for Duchenne muscular dystrophy (DMD) with mutations amenable to exon 44 skipping (DMD44).
Read More